EDIReX, a four-year project funded as part of the EU Horizon2020 Research and Innovation Program (grant agreement no #731105), kicked-off earlier this year and was introduced by project coordinator Prof. Enzo Medico at the 2018 AACR annual meeting in Chicago.
EDIReX stands for “EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts”. It will offer a cutting-edge distributed research infrastructure comprised of 6 nodes, which will provide free transnational access to PDX resources for academic and industrial cancer researchers. Infrastructure services will include distribution of cryopreserved samples, biobanking of user-developed models, and execution of drug efficacy studies. Built on the successes of the EurOPDX Consortium over the past five years, bringing together a shared collection of over 1500 PDX models, EDIReX comprises 19 partner institutions spanning 13 European countries, and aims to extend the utility of established PDX models as preclinical tools for cancer target and biomarker discovery.
The project and transnational access opportunities will be publicised further in the coming months on this website.